Search:

Infection Control Headlines from PR Newswire


< Go Back

ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection
Nancy Writebol, SIM Missionary Stricken with Ebola Virus, Declared Virus-Free and Discharged from Hospital Tuesday
E-commerce Start-Up Gives Customers STDs
Tim Krawetz of Syska Hennessy Group, Expert on Healthcare Design, Available to Speak Regarding Containment Facilities in Light of Recent Ebola Virus Reports English
Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' English Spanish
E-commerce Start-Up Gives Customers STDs
Vortex to Accelerate Anti-infective Research at the Institute for Molecular Bioscience at the University of Queensland, Australia
Ebola - More Than Medical Urgency in Liberia
Combatting Ebola Through Risk Management: What Your Company Can Do
Geisinger investigator nominated for federal award
World Vision Hopes to Rev NASCAR Fans Giving Engines for Clean Water
Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC
Globavir Seeking Approval and Launch of Novel Ebola Treatment Before Year End
SIM Missionary David Writebol Completes Medical Monitoring Period; Visits Wife Nancy at Emory University Hospital in Atlanta
New report finds missing and incomplete data imperils the global HIV/AIDS response
Dr. Jeffrey L. Sturchio Appointed President and Chief Executive Officer of Rabin Martin
New Life Sciences Research Reveals Early Stage Treatments to Help Scientists in the Fight against Ebola
Miami doctor recruited to help fight Ebola in West Africa
Equatorial Guinea Suspends Visas, Regional Flights as Part of Ebola Prevention Campaign
Germ-Killing Robots Deployed to the Republic of Liberia To Aid in Battle Against Ebola Virus
Equatorial Guinea Launches Ebola Prevention Campaign
EcoHealth Alliance Identifies Ebola's Flight Path to the U.S.
The Economic Cost of the Ebola Outbreak to West Africa
22 Companies Commit Medical Resources to Fight Ebola
TRU-D Tested in Most Comprehensive UV Disinfection Study to Date
Q-Centrix launches Infection Control solution in preparation for the CMS 2015 Final Rule
MRSA is a Major Global Health Threat
University of Maryland School of Medicine Scientist is at Forefront of Developing Vaccine for Ebola Virus
National Necrotizing Fasciitis Foundation Warns Watch Out For Vibrio Infections
Eating Almonds Associated With Reduced Inflammation In Participants With Type 2 Diabetes
Plan International: The Best Way to Predict Ebola Outbreak's Future is to invent it
Three SIM Missionaries Serving in Liberia During Ebola Outbreak Arrive in U.S.
Roka Bioscience Reports Second Quarter 2014 Financial Results
Delaware Court of Chancery Orders SIGA To Pay PharmAthene Lump Sum Expectation Damages
SIM Missionary David Writebol Shares Thoughts and Feelings in Telephone Call Today
Immediate Action Needed to Address Ebola Crisis in Liberia
Trovagene, Inc. Announces Second Quarter 2014 Financial Results
Ebola Outbreak Escalates Urgency and Spikes Visibility for Emerging Contender in Biothreat Detection -- PositiveID Corp. Investor Update by SmallCapTraders.com
Latest Ebola Crisis News Breaking on SERMO, the Number One Physician Social Network English
Leone Asset Management Issues Corporate Update for Sierra Leone
Soligenix Advances Development of a Heat Stable Rapidly Acting Anthrax Vaccine VeloThrax™
FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis
Son of SIM Missionary Nancy Writebol Issues Statement Today
Aethlon Medical (AEMD) CEO Note: A Novel Strategy To Address Ebola
New Contract to Improve the Effectiveness of High-Impact, Evidence-based HIV Interventions Awarded
SIM USA President Bruce Johnson Addresses Media upon Arrival of Ebola Patient Nancy Writebol at Emory University Hospital English
Get Smart and Get Vaccinated this August
General Hospital Reveals Fourteen Years of HIV Functional Cure: The Case of the 'Toulon Patient'
ImmunoClin Corporation (IMCL) Announces the Appointment of Infectious Disease Expert, Dr. Heinz Ellerbrok, to the Company's Scientific Advisory Board
4th Anniversary of Amanda Abbiehl's Passing Observed by Family, Friends, Physician-Patient Alliance for Health & Safety and Local Media

< Prev Next >
PR Newswire - United Business Media